Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 1, 1999StrokeOpen Access

Use of the Barthel Index and Modified Rankin Scale in Acute Stroke Trials

View Full Paper
Ask AI
Bookmark
Share

Authors

GSGeert SulterEricsson (Sweden)CSChristel SteenUniversity Medical Center GroningenJKJacques De KeyserUniversity College Hospital

Discussion

Loading...

Member takes

Implication

Randomized trial evaluates primary endpoints in acute stroke, indicating a need for consensus on outcomes.

Key Points

  • This study aims to analyze the differences in primary endpoints and definitions of outcomes in acute stroke trials using the Barthel Index and Modified Rankin Scale.
  • Analysis of efficacy trials focusing on acute stroke outcomes.
  • Comparison of definitions for favorable and poor outcomes based on Barthel Index and Modified Rankin Scale.
  • Identified significant variations in the choice of primary endpoints across trials.
  • Highlighted difficulties in defining favorable outcomes, suggesting poor outcome definitions are clearer.

Cite This Study

Sulter et al. (1999) studied this question.

synapsesocial.com/papers/69ded11a7702a00918b0ce35https://doi.org/10.1161/01.str.30.8.1538
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study Group1996 · 295 citations
  2. 2Streptokinase for Acute Ischemic Stroke With Relationship to Time of Administration1996 · 360 citations
  3. 3Tissue Plasminogen Activator for Acute Ischemic Stroke1995 · 11,761 citations
  4. 4Interobserver agreement for the assessment of handicap in stroke patients.1988 · 6,589 citations
  5. 5Are Simple Questions a Valid Measure of Outcome after Stroke?1997 · 33 citations